...
首页> 外文期刊>Cardiovascular Intervention and Therapeutics >Repetitive angioscopic observations of a sirolimus-eluting stent deployed in a patient with silent chronic thrombotic occlusion
【24h】

Repetitive angioscopic observations of a sirolimus-eluting stent deployed in a patient with silent chronic thrombotic occlusion

机译:西罗莫司洗脱支架在无症状慢性血栓闭塞患者中的重复性血管镜观察

获取原文
           

摘要

In the era of the drug-eluting stent, very late stent thrombosis has been the most serious issue in the field of interventional cardiology. A sirolimus-eluting stent (SES) was implanted in an in-stent restenotic lesion in the left circumflex artery of a 69-year-old man. Repetitive coronary angiography and angioscopy revealed that stent struts were covered with yellow neointima at 2 years after the SES deployment. At 4 years after the deployment, coronary angiography revealed the total occlusion of the SES. Angioscopy showed massive mural thrombi and yellow atherosclerotic plaques. Dual anti-platelet therapy (DAPT), ticlopidine and aspirin, had been continued since the SES deployment. Interventional cardiologists should heed the risk of silent chronic thrombotic occlusion even if struts of SES are fully covered with neointima under continued DAPT.
机译:在药物洗脱支架时代,非常晚的支架血栓形成一直是介入心脏病学领域最严重的问题。将西罗莫司洗脱支架(SES)植入到69岁男性左旋支动脉支架内再狭窄病变中。重复冠状动脉造影和血管镜检查显示,SES部署后2年,支架撑杆被黄色新内膜覆盖。部署后4年,冠状动脉造影显示SES完全闭塞。血管镜检查显示大量壁膜血栓和黄色动脉粥样硬化斑块。自从SES部署以来,双重抗血小板治疗(DAPT),噻氯匹定和阿司匹林一直在继续。即使在持续DAPT下SES支杆完全被新内膜覆盖,介入心脏病专家也应注意无声慢性血栓闭塞的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号